LUVIK GLIMEPIRIDE 2MG 30TABS

Description

LUVIK® is indicated for the treatment of type 2 diabetes mellitus.

LUVIK® can be administered as monotherapy in patients in whom glycemic control is not achieved with modifications in diet, physical exercise and weight reduction.

LUVIK® can be combined with other oral, non-betacytotropic antidiabetics, and can also be administered together with insulin.

LUVIK® is not appropriate for the treatment of type 1 diabetes mellitus (for example, for the treatment of diabetics with a history of ketoacidosis or diabetic coma).